Round Cell Liposarcoma

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma [Phase 2]

  Phase 2 clinical trial evaluating the safety and antitumor activity of Lete-Cel (GSK3377794) in HLA-A2+ patients with NY-ESO-1 positive syno…

• CLINICAL_TRIALS trial_result · 2026-02-18
  Clinical Trial Update: Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. [Phase 2]

  A Phase 2 trial evaluating the combination of trabectedin and pioglitazone in myxoid liposarcoma has completed.

• CLINICAL_TRIALS trial_result · 2025-12-03
  Clinical Trial Update: N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy [EARLY_Phase 1]

  A Phase 1 trial update on N-803 for patients with progressive synovial sarcoma and myxoid/round cell liposarcoma who previously received ado…

• CLINICAL_TRIALS trial_result · 2024-05-08
  Clinical Trial Update: Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas [Phase 1]

  Itacitinib was studied in a Phase 1 trial for patients with refractory metastatic/advanced sarcomas, but the study status is TERMINATED.

• CLINICAL_TRIALS trial_result · 2023-10-16
  Clinical Trial Update: Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma [Phase 2]

  Phase 2 study evaluating safety and antitumor activity of Lete-Cel (GSK3377794) in HLA-A2+ patients with NY-ESO-1 positive, previously untre…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-11-28
  Clinical Trial Update: Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma [Phase 2]

  Phase 2 trial of Letetresgene Autoleucel (engineered T cells) in NY-ESO-1 positive advanced myxoid/round cell liposarcoma has completed with…

• CLINICAL_TRIALS trial_result · 2019-07-10
  Clinical Trial Update: Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma [EARLY_Phase 1]

  Early Phase 1 trial of recombinant interferon gamma in soft tissue sarcoma (myxoid liposarcoma, round cell liposarcoma, synovial sarcoma) ha…